GeneDx
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $120,989 | $116,743 | $102,692 | $87,115 |
Gross Profit | 78,923 | 84,527 | 70,902 | 58,476 |
EBITDA | -10,829 | -352 | 17,571 | 236 |
EBIT | -17,710 | -6,826 | 11,380 | -5,442 |
Net Income | -17,666 | -7,635 | 10,809 | -6,529 |
Net Change In Cash | 120,989 | 116,743 | 102,692 | 87,115 |
Free Cash Flow | -7,437 | 9,595 | 8,051 | 4,053 |
Cash | 104,997 | 95,968 | 74,120 | 99,704 |
Basic Shares | 26,891 | 28,797 | 29,753 | 28,147 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $427,539 | $305,450 | $202,566 | $234,694 |
Gross Profit | 298,173 | 194,397 | 90,006 | -26,750 |
EBITDA | 6,626 | -1,260 | -136,460 | -398,198 |
EBIT | -18,598 | -23,213 | -170,194 | -457,507 |
Net Income | -21,021 | -52,286 | -175,767 | -548,980 |
Net Change In Cash | 427,539 | 305,450 | 202,566 | 234,694 |
Cost of Revenue | -263,166 | |||
Free Cash Flow | 14,262 | -33,987 | -185,858 | -333,477 |
Cash | 104,997 | 85,212 | 99,681 | 137,403 |
Basic Shares | 26,891 | 26,891 | 24,311 | 10,236 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0.14 |
2025-09-30 | $0.49 |
2025-06-30 | $0.50 |
